Mari Eccles - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Mari Eccles's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Mari Eccles

Mari Eccles

Verified

Health Reporter, POLITICO Europe

Brussels

Final Covers

Cleantech , Greentech, Medtech, Emerging Tech , SPACs, IPOs , Biotech

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 680

  • EU botches entry exam, forcing thousands of wannabe-Eurocrats to resit

    By Mari Eccles Verified, Sarah Wheaton Verified| POLITICO Europe Verified “How can EPSO be such a failure every single time?” wrote another. This test was for candidates hoping to get a job as a translator working in one of eight different EU languages. 9,663 people took partOne candidate who received the email Thursday said she had spent an hour every day for several weeks revising for the tests, which include language knowledge, verbal and numerical reasoning.

    By Mari Eccles Verified, Sarah Wheaton Verified · POLITICO Europe

    Apr. 14, 2025

  • Trump says pharma tariffs will entice back drug production. They won’t.

    By Mari Eccles Verified, Hanne COKELAERE| POLITICO Europe Verified BRUSSELS — After hitting just about every other industry he can think of (albeit with a brief pause), Donald Trump’s long-promised tariffs on drugs are around the corner. “We’re going to be announcing very shortly a major tariff on pharmaceuticals,” he said at a dinner of the National Republican Congressional Committee last week. “And when they hear that, they will leave China.

    By Mari Eccles Verified, Hanne COKELAERE · POLITICO Europe

    Apr. 13, 2025

  • EU drugs regulator rejects Lilly’s Alzheimer’s drug

    By Mari Eccles Verified| POLITICO Europe Verified The European Medicines Agency has rejected Lilly’s Alzheimer’s drug Kisunla for a license, saying its benefits don’t outweigh the risk of brain swelling or bleeding. The treatment for early Alzheimer’s disease, which is administered via a monthly infusion, has been approved in the United States, United Kingdom, Japan and China.

    By Mari Eccles Verified · POLITICO Europe

    Mar. 28, 2025

As seen in

Company Info

POLITICO Europe

POLITICO Europe is the European edition of the POLITICO network, focusing on nonpartisan political and policy journalism. Launched in April 2015, it operates as a subsidiary of Axel Springer, which fully acquired it in October 2021. Headquartered in Brussels, POLITICO Europe has offices in London, Berlin, and Paris, and it emphasizes coverage of EU politics and transatlantic policy dynamics. The company offers a range of services, including real-time digital journalism on its platform, a subscription-based policy intelligence service called POLITICO Pro, and various newsletters that provide curated political insights. It also publishes a weekly newspaper summarizing key political developments and hosts live events that facilitate discussions among policymakers, industry leaders, and journalists. POLITICO Europe targets political professionals and stakeholders, delivering actionable intelligence to help navigate policy changes.

Brussels, Brussels, Belgium

'+32 2 540 90 90

Founded: 2015